Objective: The purpose of this study was to measure the effects of an amphetamine (methylphenidate) on exercise performance at a fixed rating of perceived exertion of 16.
Methods: Eight elite cyclists ingested 10 mg methylphenidate in a randomised, placebo-controlled crossover trial.
Results: Compared with placebo, subjects receiving methylphenidate cycled for approximately 32% longer before power output fell to 70% of the starting value. At the equivalent time at which the placebo trial terminated, subjects receiving methylphenidate had significantly higher power outputs, oxygen consumptions, heart rates, ventilatory volumes and blood lactate concentrations although electromyographic activity remained unchanged. The ingestion of a centrally acting stimulant thus allowed subjects to exercise for longer at higher cardiorespiratory and metabolic stress indicating the presence of a muscular reserve in the natural state.
Conclusions: This suggests that endurance performance is not only “limited” by mechanical failure of the exercising muscles (“peripheral fatigue”). Rather performance during prolonged endurance exercise under normal conditions is highly regulated by the central nervous system to ensure that whole-body homeostasis is protected and an emergency reserve is always present.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding Funding for this research was provided by the Medical Research Council of South Africa, the University of Cape Town Harry Crossley and Nellie Atkinson Staff Research Funds, Discovery Health and the National Research Foundation of South Africa through the THRIP initiative.
Competing interests None.
Ethics approval The Research and Ethics Committee of the Faculty of Health Sciences of the University of Cape Town Medical School approved the study.